Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Prestige Brands Holdings Inc acquires Insight Pharmaceuticals Corp


Friday, 25 Apr 2014 06:37am EDT 

Prestige Brands Holdings Inc:Definitive agreement to acquire Insight Pharmaceuticals Corp.Acquisition for $750 mln in cash. 

Company Quote

34.59
1.25 +3.75%
2:21pm EST